Comparative study of two vaccines against neonatal diarrhea on a Canadian commercial farm

Home Knowledge Comparative study of two vaccines against neonatal diarrhea on a Canadian commercial farm

Comparative study of two vaccines against neonatal diarrhea on a Canadian commercial farm


The aim of this study was to assess and compare the safety and efficacy performance of two commercial vaccines registered in Canada, under field conditions, on a commercial farm where E. coli was found to be the source of diarrhea.

About this article

Appeared in

AASV Congress, 2017

Authors

Ariza, W.; Robles, D.; Badia, J.; Torrents, D.; Bernal, I.

Summary

This study shows differing diarrhea-preventive effects of the two vaccines evaluated. SUISENG® vaccine exhibited a 6-fold lower incidence of diarrhea in suckling piglets from gilts vaccinated with it than in suckling piglets from gilts vaccinated with its competitor, Vaccine B. SUISENG® vaccine also showed greater safety than Vaccine B by causing a smaller increase in post-vaccination body temperature and by not showing any local or general type reactions, which may end in abortion.

Related services

Related products

Share this on